Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort studyDaniel K. Nomah, Bibiana Morell, Juliana Reyes‐Urueña et al.|The Lancet HIV|2021Cited by 110
Impact of tenofovir on SARS-CoV-2 infection and severe outcomes among people living with HIV: a propensity score-matched studyDaniel K. Nomah, Maribel Tamayo, Juliana Reyes‐Urueña et al.|Journal of Antimicrobial Chemotherapy|2022Cited by 20
Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomesLauren E. Cain, Miguel A. Hernán, Sophie Abgrall et al.|Medicine|2016Cited by 3